Global Chemotherapy Devices Market Forecast 2026: Revenue Insights According to a newly published market research report by 24LifeSciences, global chemotherapy devices market was valued at USD 185 million in 2024 and is projected to reach USD 274 million by 2031, growing at a compound annual growth rate (CAGR) of 6.0% during the forecast period 2025–2031. Chemotherapy devices, primarily infusion pumps, are critical medical instruments designed for the precise administration of cytotoxic drugs. These devices enable controlled delivery of chemotherapy agents directly into a patient's bloodstream, which is essential for maximizing therapeutic efficacy while managing side effects. Key product categories include Large Volume Pumps (LVP), Syringe Pumps, and Elastomeric Pumps, each serving specific clinical needs across hospital and home care settings. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/6687/chemotherapy-devices-market-market

Metronidazole Market to Grow at 1.5% CAGR Through 2032 – Key Players According to a newly published market research report by 24LifeSciences, global metronidazole market was valued at USD 1.03 billion in 2024 and is projected to reach USD 1.15 billion by 2031, growing at a compound annual growth rate (CAGR) of 1.5% during the forecast period 2025–2031. Metronidazole, a nitroimidazole-class antibiotic and antiprotozoal medication, remains a cornerstone therapy for treating anaerobic bacterial infections and certain parasitic diseases. It is clinically indispensable for conditions including bacterial vaginosis, pelvic inflammatory disease, amoebiasis, giardiasis, and surgical prophylaxis. Its mechanism of action, which involves disrupting microbial DNA synthesis, continues to make it a first-line treatment in clinical guidelines worldwide despite being a mature generic product. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/6630/metronidazole-market-market

Top 10 Companies Leading the Global Phytases Market Expansion According to a newly published market research report by 24LifeSciences, global phytases market was valued at USD 458 million in 2024 and is projected to reach USD 696 million by 2031, growing at a compound annual growth rate (CAGR) of 6.2% during the forecast period 2025–2031. Phytases are phosphatase enzymes that catalyze the hydrolysis of phytic acid, an indigestible organic form of phosphorus found abundantly in grains and oilseeds. By breaking down phytic acid, these enzymes release inorganic, bioavailable phosphorus, which is crucial because it enhances the nutritional value of animal feed. This function makes phosphorus, a vital mineral, accessible to monogastric animals like poultry and swine that naturally lack the enzyme to digest it, thereby supporting better growth and reducing environmental pollution from phosphorus excretion. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/7273/phytases-market

Global Online Audio Noise Reduction Software Market Projected to Reach USD 1,026 Million by 2034, Growing at a CAGR of 8.1%; Key Players and Trends According to a new report from Intel Market Research, the global Online Audio Noise Reduction Software market was valued at USD 601 million in 2025 and is projected to reach USD 1,026 million by 2034, growing at a CAGR of 8.1% during the forecast period (2026-2034). 📥 Download FREE Sample Report: https://www.intelmarketresearch.com/download-free-sample/36515/online-audio-noise-reduction-software-market 🌐 Website: https://www.intelmarketresearch.com 📞 Asia-Pacific: +91 9169164321 🔗 LinkedIn: Follow Us

Global Home Portable Oxygen Concentrator Market to Reach USD 334 Million by 2032 | CAGR 4.8% According to a newly published market research report by 24LifeSciences, global home portable oxygen concentrator market was valued at USD 243 million in 2024 and is projected to reach USD 334 million by 2032, growing at a compound annual growth rate (CAGR) of 4.8% during the forecast period 2025-2032. Home portable oxygen concentrators are medical devices that extract oxygen from ambient air and deliver it to patients requiring supplemental oxygen therapy. These compact, battery-operated units utilize either electronic oxygen generation or molecular sieve technology to provide continuous flow or pulse-dose oxygen delivery. The devices are particularly valuable for patients with chronic respiratory conditions such as COPD, pulmonary fibrosis, and other oxygen-deficiency disorders who require mobility while receiving therapy. Their established efficacy in enabling active lifestyles while managing respiratory conditions continues to underpin their importance in home healthcare and pulmonary medicine. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/393/home-portable-oxygen-concentrator-market

Global High Viscosity Bead Mill Market Projected to Reach USD 1,006 Million by 2034, Growing at a CAGR of 6.1%; Key Players and Trends According to a new report from Intel Market Research, the global High Viscosity Bead Mill market was valued at USD 671 million in 2025 and is projected to reach USD 1,006 million by 2034, growing at a steady CAGR of 6.1% during the forecast period (2026–2034). 📥 Download Sample Report: https://www.intelmarketresearch.com/download-free-sample/35778/high-viscosity-bead-mill-market 🌐 Website: https://www.intelmarketresearch.com 📞 Asia-Pacific: +91 9169164321 🔗 LinkedIn: Follow Us

Global Agaricus Blazei Murill Extract Market Projected to Reach USD 215.9 Million by 2034, Growing at a CAGR of 5.8%; Key Players and Trends According to a new report from Intel Market Research, the global Agaricus Blazei Murill Extract market was valued at USD 125.4 million in 2025 and is projected to reach USD 215.9 million by 2034, growing at a steady CAGR of 5.8% during the forecast period. 📥 Download FREE Sample Report: https://www.intelmarketresearch.com/download-free-sample/34091/agaricus-blazei-murill-extract-market 🌐 Website: https://www.intelmarketresearch.com 📞 Asia-Pacific: +91 9169164321 🔗 LinkedIn: Follow Us

Bicycle Peripheral Market to Grow at a CAGR of 5.7% from 2026 to 2034 – Key Players to Watch According to a new report from Intel Market Research, the global bicycle peripheral market was valued at USD 8.42 billion in 2025 and is projected to reach USD 14.78 billion by 2034, growing at a steady CAGR of 5.7% during the forecast period (2026-2034). 📥 Download FREE Sample Report: https://www.intelmarketresearch.com/download-free-sample/33404/bicycle-peripheral-market 🌐 Website: https://www.intelmarketresearch.com 📞 Asia-Pacific: +91 9169164321 🔗 LinkedIn: Follow Us

PKU Market to Grow at 11% CAGR Through 2032 – Emerging Treatments According to a newly published market research report by 24LifeSciences, global Phenylketonuria (PKU) market was valued at USD 1.35 billion in 2024 and is projected to reach USD 2.77 billion by 2031, growing at a compound annual growth rate (CAGR) of 11.0% during the forecast period 2025–2031. Phenylketonuria (PKU) is a rare inherited metabolic disorder characterized by a deficiency of the enzyme phenylalanine hydroxylase (PAH), which is essential for metabolizing the amino acid phenylalanine. This deficiency leads to a dangerous accumulation of phenylalanine in the blood, which, if left untreated, can cause severe and irreversible neurological damage, intellectual disability, seizures, and behavioral issues. Lifelong management through a strict phenylalanine-restricted diet remains the foundation of treatment, though pharmaceutical options have expanded significantly in recent years. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/6724/phenylketonuria-pku-market-market

How Europe regulations favoring Global TMAB high-purity catalyst adoption? Tetramethylammonium bromide has become indispensable in specialty chemical manufacturing due to its ionic properties and versatility. Its role in quaternary ammonium compound synthesis continues to expand alongside advancements in catalyst technologies and battery research, positioning it as a key material in next-generation chemical processes. Download FREE Sample Report: https://www.24chemicalresearch.com/download-sample/284859/global-regional-tetramethylammonium-bromide-forecast-supply-dem-analysis-competitive-market-2025-2032-697

Sinus Balloon Dilation System Market to Grow at 5.7% CAGR Through 2032 According to a newly published market research report by 24LifeSciences, global Sinus Balloon Dilation System market was valued at USD 52.6 million in 2024 and is projected to reach USD 77.1 million by 2031, growing at a compound annual growth rate (CAGR) of 5.7% during the forecast period 2025–2031. The Sinus Balloon Dilation System is a medical device used to treat sinusitis or sinus blockage. The system employs a non-invasive treatment method that is widely used in the field of ENT (Ear, Nose, and Throat) to address chronic rhinosinusitis (CRS). CRS affects approximately 12.5% of the U.S. population, with over 30 million Americans diagnosed annually. The system works by introducing an uninflated balloon catheter into the affected sinus and then slowly inflating the balloon to dilate the sinus ostia and spaces associated with the paranasal sinus cavities, thereby restoring normal drainage and relieving symptoms. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/5473/sinus-balloon-dilation-system-market

Prilled Urea Market’s CAGR of 0.1%: Top 10 Companies Leading the Charge in 2034 According to a new report from Intel Market Research, the global Prilled Urea market was valued at USD 51.93 billion in 2025 and is projected to reach USD 52.89 billion by 2034, growing at a CAGR of 0.1% during the forecast period (2026–2034). 📥 Download FREE Sample Report: https://www.intelmarketresearch.com/download-free-sample/35936/prilled-urea-market 🌐 Website: https://www.intelmarketresearch.com 📞 Asia-Pacific: +91 9169164321 🔗 LinkedIn: Follow Us